Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KeraFactor
- Development stage
- Unknown
- Lead developer
- Skin Sciences
- Modality
- Recombinant Proteins and Enzymes, Peptides, Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
KeraFactor is a specialized topical formulation designed to address hair thinning and promote scalp health by replenishing specific growth factors and proteins that are often deficient in thinning hair. Developed by SkinScience, the product utilizes a proprietary blend of seven bio-identical growth factors and proteins, including Keratinocyte Growth Factor (KGF), Vascular Endothelial Growth Factor (VEGF), and Fibroblast Growth Factor-2 (FGF-2). These active ingredients are encapsulated in a unique nanoliposome delivery system known as "KeraLiposomes," which facilitates enhanced penetration into the hair follicles. KeraFactor is frequently used as a standalone topical treatment or in conjunction with laser-assisted delivery systems, such as Lutronic's LaseMD, to optimize absorption and efficacy in treating androgenetic alopecia and other forms of non-scarring hair loss.
- Brand names
- KeraFactorKeraFactor SerumKeraFactor Scalp Stimulating Solution
- Other names
- KeraFactor Peptide Complex
02
Targets
FGFR1 (Fibroblast growth factor receptor 1)FGFR2 (Keratinocyte growth factor receptor)IGF-1R (Insulin-like growth factor 1 receptor)VEGFR (VEGFR family)
Beyond the preview
Go deeper on KeraFactor.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KeraFactor.